The Hydropothecary Corporation (TSXV:THCX) announced it will graduate its common shares from the TSX Venture Exchange (TSXV) into the Toronto Stock Exchange (TSX). The company will seek shareholder approval to change its name as well.
As quoted in the press release:
The common shares and warrants will commence trading on the TSX effective Friday, June 22, 2018, at which time the Company will also “ring the bell” to open the TSX. In conjunction with listing on TSX, the common shares and warrants will be voluntarily delisted from the TSX-V effective upon commencement of trading on the TSX.
“Graduating to a major exchange such as the TSX demonstrates Hydropothecary’s growth and proven ability to execute,” said Sebastien St-Louis, Hydropothecary’s Chief Executive Officer and co-founder.
The common shares and warrants will trade under the symbols “HEXO” and “HEXO.WT” respectively. The Company has previously announced the launch of HEXO as its new brand for the adult-use cannabis market, while continuing to use the Hydropothecary brand for the medical cannabis market.
In addition, further to the Company’s launch of the HEXO brand, the Company wishes to announce that it intends to change its corporate name from The Hydropothecary Corporation to HEXO Corp. In connection with the name change, the Company will call a special meeting of its shareholders to seek shareholder approval for the change of its corporate name. The Company intends to complete the corporate name change as soon as practicable following receipt of shareholder approval and any requisite regulatory approvals.
Click here to read the full press release.
The post Hydropothecary Announces TSX Uplisting appeared first on Investing News Network.